1 |
Ahlgren J, Stal O, Westmaan G, Arnesson LG (1994). Prediction of axillary lymph node metastases in a screened breast cancer population. Acta Oncol, 33, 603-8.
DOI
|
2 |
Artaman A (2010). Cancer report. Windsor-Essex Country. 1-134.
|
3 |
Bader AA, Tio J, Petru E, et al (2002). T1 breast cancer: identification of patients at low risk of axillary lymph node metastases. Breast Cancer Res Treat, 76, 11-7.
DOI
ScienceOn
|
4 |
Bourez RL, Rutgers EJ, Van De Velde CJ (2002). Will We Need Lymph Node Dissection at All in the Future? Clin Breast Cancer, 3, 315-22.
DOI
ScienceOn
|
5 |
Chua B, Ung O, Taylor R, Boyages J (2001). Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg, 71, 723-8.
DOI
ScienceOn
|
6 |
Cianfrocca M, Goldstein LJ (2004). Prognostic and predictive factors in early-stage breast cancer. Oncologist Breast Cancer, 9, 606-16
|
7 |
Colleoni M, Rotmensz N, Maisonneuve P, et al (2007). Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol, 18, 1632-40.
DOI
ScienceOn
|
8 |
Colleoni M, Rotmensz N, Peruzzotti G, et al (2005). Size of breast cancer metastases in axillary lymph nodes. Clinical Relevance of Minimal Lymph Node Involvement, 23, 1379-89.
|
9 |
El-Bolkainy MN (2000). Topographic pathology of cancer. 2nd ed., NCI, Cairo University.
|
10 |
Ernst MF, Voogd AC, Balder W, Klinkenbijl JH, Roukema JA (2002). Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol, 79, 151-5.
DOI
ScienceOn
|
11 |
Gajdos C, Tartter PI, Bleiweiss IJ (1999). Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Annals Surg, 230, 692-6.
DOI
|
12 |
Garcia M et al. Global Cancer Facts & Figures 2011-2012 Atlanta (Breast Cancer), Am Cancer Society. 1-36.
|
13 |
Giuliano AE, Hunt KK, Ballman KV, et al (2011). Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis a randomized clinical trial. MDJAMA, 305, 569-75.
|
14 |
Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994). Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 220, 391-401.
DOI
ScienceOn
|
15 |
Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A (2000). Breast cancer in Iran: a review of 903 case records. Public Health, 114, 143-5.
|
16 |
International (Ludwig) Breast Cancer Study Group (1990). Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet, 335, 1565-8.
|
17 |
Jemal A, Bray F, Ferlay J, Ward E, Forman D (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
18 |
Kang HS, Noh DY, Youn YK, Oh SK, Choe KJ (1999). The predictors of axillary node metastasis in 2 cm or less breast cancer univariate and multivaritate analysis. J Korean Breast Cancer Soc, 2, 7-13.
DOI
|
19 |
Lee JH, Kim SH, Suh YJ, Shim BY, Kim HK (2010). Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size. Cancer Res Treat, 42, 30-6.
DOI
ScienceOn
|
20 |
Krag DN, Weaver DL, Alex JC, Fairbank JT (1993). Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol, 2, 335-40.
DOI
ScienceOn
|
21 |
Mann GB, Rizza C, Tan LK, Borgen PI, Van Zee KJ (1999). Six-year follow-up of patients with microinvasive, T1a, and T1b breast cancinoma. Ann Surg Oncol, 6, 591-8.
DOI
|
22 |
Mincey BA, Bammer T, Atkinson EJ, Perez EA (2001). Role of axillary node dissection in patients with T1a and T1b breast cancer. Arch Surg, 136, 779-82.
DOI
ScienceOn
|
23 |
Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007) Breast cancer in Iran: an epidemiological review. Breast J. 13, 383-91.
DOI
ScienceOn
|
24 |
Pappo I, Karnia T, Sandbank J, et al (2007). Breast cancer in the elderly: histological, hormonal and surgical characteristics. The Breast, 16, 60-7.
DOI
ScienceOn
|
25 |
Pathy NB, Yip CH, Taib NA, et al (2011). Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry. The Breast, 20, 75-80
|
26 |
Port ER, Tan LK, Borgen PI, et al (1998). Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma. Ann Surg Oncol, 5, 23-7.
DOI
ScienceOn
|
27 |
Rosen PP, Groshen S, Kinne DW, Norton L (1993). Factors influencing prognosis in nodenegative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol, 11, 2090-100.
|
28 |
Silverstein MJ, Skinner KA, Lomis TJ (2001). Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg, 25, 767-72.
DOI
ScienceOn
|
29 |
Takei H, Kurosumi M, Yoshida T, et al (2009). Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer, The Breast, 18, 244-7.
DOI
ScienceOn
|
30 |
Stankov S, Stankov K (2011). Descriptive epidemiology of breast cancer in Vojvodina. The Breast, 20, 192-5.
DOI
ScienceOn
|
31 |
Wasserberg N, Morgenstern S, Schachter J, et al (2002). Risk factors for lymph node metastases in breast ductal carcinoma in situ with minimal invasive component. Arch Surg, 137, 1249-52
DOI
ScienceOn
|
32 |
Westenend PJ, Meurs CJC, Damhuis RAM (2005) Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasis. J Clin Pathol, 58, 196-201.
DOI
ScienceOn
|
33 |
World Health Organization: Cancer. [http://www.who.int/mediacentre/factsheets/fs297/en] website
|
34 |
Yenidunya S, Bayrak R, Haltas H (2011). Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma. Diagnostic Pathology, 6,18
DOI
ScienceOn
|
35 |
Zaghloul AS, Ghoneim WA, El-Moneim TA, et al (2001). Patterns of axillary lymph node metastasis from breast cancer in Egyptian patients. J Egyptian Nat Cancer Inst, 13, 1-8.
|